Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. (Q40901543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

review article

1 reference

title

Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

Hedner U

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Glazer S

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Falch J

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

1 reference

1 April 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Medicine Reviews

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

78-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Characterization of a cDNA coding for human factor VII

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2893%2970126-1

7 January 2021

10.1016/S0887-7963(93)70126-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8481602%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference